Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Mederi lanzará tecnología Stretta RFT3 mejorada, presentará nuevos datos en la Semana de las Enfermedades Digestivas de 2016
  • USA - Deutsch
  • USA - English
  • USA - Français
  • USA - español
  • Brazil - Português
  • India - English
  • USA - Italiano


News provided by

Mederi Therapeutics Inc.

May 03, 2016, 10:39 ET

Share this article

Share toX

Share this article

Share toX

NORWALK, Connecticut, 3 de mayo de 2016 /PRNewswire/ -- Mederi Therapeutics Inc., fabricante de la terapia Stretta para la enfermedad por reflujo gastroesofágico (ERGE), anunció hoy el lanzamiento de RFT3, la tercera generación de la tecnología Stretta. El nuevo producto se lanzará en la Digestive Disease Week® (Semana de las Enfermedades Digestivas, DDW) de 2016, que se celebrará del 21 al 24 de mayo en San Diego. Además, los datos del estudio de seguimiento de Stretta durante 10 años en poblaciones especiales de pacientes con ERGE se presentarán en varias sesiones de afiches de la DDW.

Learn about the latest update to the original innovator in non-surgical GERD treatment...Stretta Therapy. The Stretta RFT3 is the next generation of the clinically proven Stretta system with added features that further facilitate ease of use and optimal treatment of chronic GERD sufferers. Stretta RFT3, the RE-generation of a proven treatment for a challenging patient population.
Learn about the latest update to the original innovator in non-surgical GERD treatment...Stretta Therapy. The Stretta RFT3 is the next generation of the clinically proven Stretta system with added features that further facilitate ease of use and optimal treatment of chronic GERD sufferers. Stretta RFT3, the RE-generation of a proven treatment for a challenging patient population.

Logo - http://photos.prnewswire.com/prnh/20160502/362660

La nueva Stretta RFT3 es una regeneración del sistema Stretta, clínicamente probado. Aunque el procedimiento sigue siendo el mismo, nuevas mejoras estéticas, funcionales y materiales facilitarán aún más el uso y el suministro óptimo del tratamiento con Stretta para pacientes crónicos de ERGE.

"Estamos escuchando constantemente a nuestros usuarios en todo el mundo y utilizando esas respuestas para hacer mejoras incrementales a nuestro sistema", dijo Bob Knarr, director ejecutivo de Mederi. "La tercera generación de Stretta ofrece interfaces mejoradas, y la automatización de ciertas funciones para mejorar la usabilidad y optimizar el tratamiento. Los nuevos catéteres RFT3 son compatibles con el actual Generador MDRF1, lo que permite una versatilidad máxima de la tecnología mejorada. Estos mejoramientos demuestran el continuo compromiso de Mederi con productos de calidad".

Alrededor del 30% de los adultos padecen de ERGE crónica. Muchos de estos pacientes no responden completamente a los inhibidores de la bomba de protones (PPI), el medicamento más común para este padecimiento, y muchos más están preocupados por los riesgos asociados con el uso a largo plazo de los PPI, o con la cirugía contra el reflujo. Stretta ofrece una opción intermedia no quirúrgica para este paciente.

Mederi presentará y mostrará el nuevo sistema Stretta RFT3 en el Centro de Aprendizaje ASGE en la DDW. Las demostraciones tendrán lugar en las siguientes fechas:

  • Sábado 21 de mayo: Demostración práctica 1:00­-4:00 p.m.; Presentación 1:00-2:00 p.m.
  • Domingo 22 de mayo: Demostración práctica 8:00 a.m.-12:00 p.m.; Presentación 9:00-10:00 a.m.
  • Lunes 23 de mayo: Demostración práctica 1:00-4:00 p.m.; Presentación 1:00-2:00 p.m.
  • Martes 24 de mayo: Demostración práctica 1:00-4:00 p.m.; Presentación 2:00-3:00 p.m.

En la DDW, los datos de Stretta durante 10 años, provenientes de estudios realizados por el doctor Mark Noar, director del Centro de Estudios del Reflujo y la Acidez en Towson, Maryland, se presentarán en varias sesiones de afiches. Tres presentaciones examinarán a subgrupos de pacientes específicos del estudio de 10 años publicado con anterioridad, y analizarán el efecto de Stretta en pacientes con un elevado Índice de Masa Corporal (IMC), síntomas respiratorios de ERGE, y pacientes con ERGE recurrente después de una cirugía contra el reflujo. "Es muy importante tener una opción de tratamiento no quirúrgica contra la ERGE para estas poblaciones de pacientes difíciles", observó el doctor Noar.

Para más detalles sobre la nueva Stretta RFT3 y los datos clínicos más recientes, visite la sección 3349 de Mederi en la DDW 2016.

Acerca de Mederi Therapeutics Inc. y la Terapia Stretta®
Mederi fabrica dispositivos innovadores no quirúrgicos que usan la energía no ablativa de radiofrecuencia (RF) para tratar las enfermedades digestivas. La terapia Stretta de Mederi ha demostrado ser segura y eficaz para el tratamiento de ERGE en más de 40 estudios, todos demostrando un alto nivel de seguridad y eficacia y de alivio de los síntomas a largo plazo. Se han realizado más de 20.000 procedimientos de Stretta en todo el mundo, y está disponible en más de 40 países.

Para más información, visite: www.stretta-therapy.com.

Contacto para los medios
Mike Elofer
[email protected]
+1 (484) 620-6167

FUENTE Mederi Therapeutics Inc.

Related Links

http://www.mederitherapeutics.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.